Avitar, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVTI research report →
Companywww.avitarinc.com
Avitar, Inc. is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy.
- CEO
- Cory H. Gelmon
- IPO
- 1994
- Employees
- 36
- HQ
- Canton, MA, US
Price Chart
Valuation
- Market Cap
- $1.38K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -3.10
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 26.94%
- Op Margin
- 87.98%
- Net Margin
- -72.75%
- ROE
- 25.07%
- ROIC
- -203.85%
Growth & Income
- Revenue
- $3.11M · -36.93%
- Net Income
- $-2,259,629 · 38.98%
- EPS
- $-0.11 · 85.53%
- Op Income
- $2.73M
- FCF YoY
- 36.42%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -51.52
- Avg Volume
- 22.25K
Get TickerSpark's AI analysis on AVTI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our AVTI Coverage
We haven't published any research on AVTI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AVTI Report →